chevron_leftBack
As of 20 June 2026, Mediera Corp. has a market cap of $31.99M USD, ranking #33801 globally and #2080 in Taiwan.
It ranks #3057 in the Healthcare sector, and #1047 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$31.99MUSD
1.01B TWD
Enterprise Value
$28.84MUSD
912.55M TWD
Revenue (TTM)
$7.27MUSD
229.85M TWD
EBITDA (TTM)
$608.2KUSD
19.24M TWD
Net Income (TTM)
$548.9KUSD
17.36M TWD
EBITDA Margin
8.4%
Profit Margin
7.6%
PE Ratio
58.4
PS Ratio
4.4
PB Ratio
1.9
EV/EBITDA
39.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1967
Website
mediera.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | -1% | -12% | -7.5% | 7.3% | 15% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
5398
慕康生技醫藥股份有限公司
ISIN: TW0005398002
Shares Out.:
Shares Outstanding:
49.466M1
Shares Float:
40.034M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
20.20 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Mediera Corp.
Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.76B
24K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.83B
6K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$920.72M
3K%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$805.08M
2K%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$785.01M
2K%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$581.1M
2K%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$318.3B
995K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
890K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
857K%
|
15.1
|
chevron_leftBack